Exagen (XGN) Key Ratios

$7.67

up-down-arrow $0.07 (0.92%)

As on 26-Aug-2026 16:00EDT

Market cap

info icon

$192 Mln

Revenue (TTM)

info icon

$71 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

15.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 15.23 15.92 20.83 10.35 8.73
EBIT 25.11 39.14 2.67 14.49 4.13
Net Profit 19.44 28.00 -11.44 13.49 1.39
EPS 20.47 37.18 7.88 16.82 7.57
Book Value -- -- 54.44 -31.05 -24.53
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -29.04-47.23-19.35-23.41-23.13
Net Margin info ---55.57-26.61----
Return on equity info -104.78-86.22-127.58-147.85-93.78
Return on Capital info -43.11-41.72---52.57-38.43
Return on Assets info -33.90-34.70-28.15-38.85-29.74
Debt to Equity (x) info ----1.831.472.43
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
-52.57
-38.43
-38.34
-49.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-127.58

Lower than Peers by 135.54

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-127.58
-147.85
-93.78
-72.72
-74.39
Peer Median
7.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-28.15

Lower than Peers by 30.29

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-28.15
-38.85
-29.74
-33.09
-45.20
Peer Median
2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-19.35

Lower than Peers by 26.40

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-19.35
-23.41
-23.13
-40.57
-99.25
Peer Median
7.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-26.61

Lower than Peers by 29.76

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-26.61
-29.97
-27.17
-45.08
-104.00
Peer Median
3.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

20.83

Higher than Peers by 11.00

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
20.83
0.20
0.06
0.15
-0.06
Peer Median
9.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

2.67

Lower than Peers by 13.53

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
2.67
-21.08
39.64
52.85
-88.02
Peer Median
16.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-11.44

Lower than Peers by 28.62

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-11.44
-31.99
36.19
50.01
-76.48
Peer Median
17.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

7.88

Lower than Peers by 8.22

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
7.88
-0.11
0.37
0.52
-0.74
Peer Median
16.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-49.32

Lower than Peers by 54.44

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-49.32
--
--
--
--
Peer Median
5.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

1.83

Higher than Peers by 1.45

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
1.83
1.47
2.43
1.02
0.83
Peer Median
0.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.13

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
0.13
0.17
0.18
0.05
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.18

Higher than Peers by 1.71

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
3.18
3.45
2.70
4.02
7.55
Peer Median
1.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.18

Higher than Peers by 1.80

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
3.18
--
--
3.78
7.36
Peer Median
1.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-2.69

Lower than Peers by 7.01

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-2.69
-3.61
-5.76
-9.13
-18.47
Peer Median
4.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

17.44

Higher than Peers by 4.32

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
17.44
16.30
14.08
12.47
13.34
Peer Median
13.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.06

Higher than Peers by 0.28

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
1.06
1.30
1.09
0.73
0.43
Peer Median
0.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
51.27
47.22
43.89
63.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
--
46.55
36.90
21.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
54.51
58.92
48.85
41.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
--
34.85
31.94
43.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
-6.57
-4.94
-1.50
-0.87
Peer Median
33.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

15.71

Higher than Peers by 12.16

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
15.71
7.51
7.82
1.56
0.97
Peer Median
3.54
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-0.16

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
-0.16
-9.25
-6.80
-1.16
-0.32
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

192

Lower than Peers by 179

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Exagen (XGN)
192
--
--
--
--
Peer Median
371
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...